May 10, 2023
When sophisticated drug and device companies have confronted deadly diseases and daunting approval standards, they've hired the brightest scientific and legal minds — or bribed prescribers with cash, liquor, steaks, vacations and lap dances. The latter approach undergirds a landmark law that has been fueling litigation for 50 years and enters its next half-century chasing a new generation of camouflaged kickbacks.